Cargando…

Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules

BACKGROUND: Thyroid nodules affect up to 65% of the population. Although fine needle aspirate (FNA) cytology is the gold standard for diagnosis, 15–30% of results are indeterminate. Molecular testing may aid in the diagnosis of nodules and potentially reduce unnecessary surgery. However, these tests...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dharampal, Navjit, Smith, Kristine, Harvey, Adrian, Paschke, Ralf, Rudmik, Luke, Chandarana, Shamir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773581/ https://www.ncbi.nlm.nih.gov/pubmed/36544210 http://dx.doi.org/10.1186/s40463-022-00604-7

Ejemplares similares

Indeterminate Thyroid Nodules: From Cytology to Molecular Testing
por: Vignali, Paola, et al.
Publicado: (2023)

Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules
por: Kwon, Hyemi, et al.
Publicado: (2016)

Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification
por: Zhou, Yuanyuan, et al.
Publicado: (2023)

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021)

Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules
por: Goldner, Whitney S., et al.
Publicado: (2019)

Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology
por: Sciacchitano, Salvatore, et al.
Publicado: (2017)

Q-Elastography in the Presurgical Diagnosis of Thyroid Nodules with Indeterminate Cytology
por: Cantisani, Vito, et al.
Publicado: (2012)

Cost Impact of Molecular Testing for Indeterminate Thyroid Nodule Fine-Needle Aspiration Biopsies
por: Yip, Linwah, et al.
Publicado: (2012)

Multiplatform molecular test performance in indeterminate thyroid nodules
por: Lupo, Mark A., et al.
Publicado: (2020)

Critical analysis of molecular tests in indeterminate thyroid nodules
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate
por: Wu, Dandan, et al.
Publicado: (2020)

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma
por: Pongsapich, Warut, et al.
Publicado: (2019)

A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology
por: Kloos, Richard T., et al.
Publicado: (2016)

Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations
por: Whitmer, Dorota, et al.
Publicado: (2022)

Long-term Follow-up of Cytologically Indeterminate Thyroid Nodules Found Benign on Molecular Testing: A Validation Study
por: White, Michelle K., et al.
Publicado: (2022)

The run for a million continues: is there still space for traditional techniques beyond molecular testing for indeterminate thyroid nodule cytology?
por: Ferraz, Carolina
Publicado: (2020)

Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
por: Rowe, Leslie R, et al.
Publicado: (2006)

Evaluation and Management of Indeterminate Thyroid Nodules: The Revolution of Risk Stratification Beyond Cytological Diagnosis
por: Valderrabano, Pablo, et al.
Publicado: (2017)

The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
por: Sencar, Muhammed Erkam, et al.
Publicado: (2022)

An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules
por: Taccogna, Silvia, et al.
Publicado: (2022)

Cost effectiveness of intraoperative pathology in the management of indeterminate thyroid nodules
por: Vuong, Christopher D., et al.
Publicado: (2020)

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study
por: Bardet, Stéphane, et al.
Publicado: (2020)

Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules
por: Zhou, Ling, et al.
Publicado: (2023)

Genetic testing for indeterminate thyroid cytology: review and meta-analysis
por: Vargas-Salas, Sergio, et al.
Publicado: (2017)

Local molecular analysis of indeterminate thyroid nodules
por: Gill, Mandeep S., et al.
Publicado: (2015)

Indeterminate thyroid nodules in the era of molecular genomics
por: Rao, Sarika N., et al.
Publicado: (2020)

Risk assessment of cytologically indeterminate thyroid nodules with integrated molecular testing and repeat biopsy: a surgical decision-oriented tool
por: Guan, Xuhuizi, et al.
Publicado: (2023)

Analytical Verification Performance of Afirma Genomic Sequencing Classifier in the Diagnosis of Cytologically Indeterminate Thyroid Nodules
por: Hao, Yangyang, et al.
Publicado: (2019)

OR27-2 Inter-reader Agreement of ATA Sonographic Risk In Thyroid Nodules With Indeterminate Cytology
por: Linares, Maria, et al.
Publicado: (2019)

ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology
por: Barbosa, Thayse Lozovoy Madsen, et al.
Publicado: (2019)

Diagnostic performance of Midkine ratios in fine-needle aspirates for evaluation of Cytologically indeterminate thyroid nodules
por: Zhou, Le, et al.
Publicado: (2021)

Malignancy Risk in RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Real-World Clinical Experience
por: Lu, Joseph, et al.
Publicado: (2021)

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2022)

ThyroidPrint®: clinical utility for indeterminate thyroid cytology
por: Olmos, Roberto, et al.
Publicado: (2023)

Indeterminate Thyroid Nodules: When to Worry?
por: Tibbels, Amanda
Publicado: (2023)

MON-LB79 Do Ultrasound Patterns and Clinical Parameters Modify the Probability of Thyroid Cancer Predicted by Molecular Testing in Thyroid Nodules With Indeterminate Cytology?
por: Figge, James J, et al.
Publicado: (2020)

The Mcgill thyroid nodule score – does it help with indeterminate thyroid nodules?
por: Varshney, Rickul, et al.
Publicado: (2015)

PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing
por: Marzocchi, Carlotta, et al.
Publicado: (2022)

Longitudinal Assessment of Quality of Life Following Molecular Testing for Indeterminate Thyroid Nodules
por: Schumm, Max A., et al.
Publicado: (2021)

Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?
por: Ferraz, Carolina
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ljn24ku1rc2llargedjsrp7s31